Shiro Ibe

892 total citations
28 papers, 662 citations indexed

About

Shiro Ibe is a scholar working on Infectious Diseases, Virology and Hepatology. According to data from OpenAlex, Shiro Ibe has authored 28 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 21 papers in Virology and 6 papers in Hepatology. Recurrent topics in Shiro Ibe's work include HIV/AIDS drug development and treatment (22 papers), HIV Research and Treatment (21 papers) and HIV/AIDS Research and Interventions (17 papers). Shiro Ibe is often cited by papers focused on HIV/AIDS drug development and treatment (22 papers), HIV Research and Treatment (21 papers) and HIV/AIDS Research and Interventions (17 papers). Shiro Ibe collaborates with scholars based in Japan, Iran and Ghana. Shiro Ibe's co-authors include Katsuhiko Sato, Mami Hata, Kenji Sakae, Masahiro Suzuki, Masakado Matsumoto, Masao Takahashi, Tsuguhiro Kaneda, Junko Hattori, Makoto Utsumi and Wataru Sugiura and has published in prestigious journals such as PLoS ONE, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Shiro Ibe

28 papers receiving 638 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shiro Ibe Japan 12 324 294 218 164 104 28 662
Alejandro Pironti United States 12 153 0.5× 94 0.3× 247 1.1× 120 0.7× 93 0.9× 37 569
Rubén González-Sanz Spain 14 136 0.4× 140 0.5× 194 0.9× 187 1.1× 103 1.0× 20 569
Müşerref Tatman‐Otkun Türkiye 10 75 0.2× 46 0.2× 107 0.5× 85 0.5× 69 0.7× 18 354
Euloge Ekaza Ivory Coast 11 208 0.6× 126 0.4× 47 0.2× 233 1.4× 71 0.7× 30 456
Joe Huong United States 7 277 0.9× 38 0.1× 86 0.4× 232 1.4× 86 0.8× 8 559
Salih Türkoğlu Türkiye 9 106 0.3× 13 0.0× 356 1.6× 118 0.7× 121 1.2× 20 500
Brenda Beckthold Canada 10 174 0.5× 122 0.4× 92 0.4× 83 0.5× 13 0.1× 13 415
Metin Otkun Türkiye 10 86 0.3× 52 0.2× 49 0.2× 74 0.5× 17 0.2× 21 319
Jill S. Garlick Australia 5 92 0.3× 18 0.1× 436 2.0× 157 1.0× 172 1.7× 5 607
L. Mensa Spain 12 97 0.3× 11 0.0× 85 0.4× 131 0.8× 83 0.8× 18 358

Countries citing papers authored by Shiro Ibe

Since Specialization
Citations

This map shows the geographic impact of Shiro Ibe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiro Ibe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiro Ibe more than expected).

Fields of papers citing papers by Shiro Ibe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiro Ibe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiro Ibe. The network helps show where Shiro Ibe may publish in the future.

Co-authorship network of co-authors of Shiro Ibe

This figure shows the co-authorship network connecting the top 25 collaborators of Shiro Ibe. A scholar is included among the top collaborators of Shiro Ibe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiro Ibe. Shiro Ibe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsuda, Masakazu, Shiro Ibe, Michiko Nemoto, et al.. (2022). Evaluation of the Geenius HIV 1/2 confirmatory assay for HIV-2 samples isolated in Japan. Journal of Clinical Virology. 152. 105189–105189. 1 indexed citations
2.
Nii-Trebi, Nicholas Israel, J. A. M. Brandful, Shiro Ibe, et al.. (2017). Dynamic HIV-1 genetic recombination and genotypic drug resistance among treatment-experienced adults in northern Ghana. Journal of Medical Microbiology. 66(11). 1663–1672. 10 indexed citations
3.
Fujisaki, Seiichiro, Junko Hattori, Teiichiro Shiino, et al.. (2015). HIV-1 CRF01_AE and Subtype B Transmission Networks Crossover: A New AE/B Recombinant Identified in Japan. AIDS Research and Human Retroviruses. 32(5). 412–419. 8 indexed citations
4.
Yoshida, S., Junko Hattori, Masakazu Matsuda, et al.. (2014). Japanese External Quality Assessment Program to Standardize HIV-1 Drug-Resistance Testing (JEQS2010 Program) Using In Vitro Transcribed RNA as Reference Material. AIDS Research and Human Retroviruses. 31(3). 318–325. 4 indexed citations
5.
Jahanbakhsh, Fatemeh, Junko Hattori, Masakazu Matsuda, et al.. (2013). Prevalence of Transmitted HIV Drug Resistance in Iran between 2010 and 2011. PLoS ONE. 8(4). e61864–e61864. 41 indexed citations
6.
Nii-Trebi, Nicholas Israel, Shiro Ibe, Koichi Ishikawa, et al.. (2013). HIV-1 Drug-Resistance Surveillance among Treatment-Experienced and -Naïve Patients after the Implementation of Antiretroviral Therapy in Ghana. PLoS ONE. 8(8). e71972–e71972. 27 indexed citations
7.
Miyamoto, Tadashi, Emi E. Nakayama, Masaru Yokoyama, et al.. (2012). The Carboxyl-Terminus of Human Immunodeficiency Virus Type 2 Circulating Recombinant form 01_AB Capsid Protein Affects Sensitivity to Human TRIM5α. PLoS ONE. 7(10). e47757–e47757. 6 indexed citations
8.
Jahanbakhsh, Fatemeh, Shiro Ibe, Junko Hattori, et al.. (2012). Molecular Epidemiology of HIV Type 1 Infection in Iran: Genomic Evidence of CRF35_AD Predominance and CRF01_AE Infection Among Individuals Associated with Injection Drug Use. AIDS Research and Human Retroviruses. 29(1). 198–203. 24 indexed citations
9.
Fujisaki, Seiichiro, Yoshiyuki Yokomaku, Teiichiro Shiino, et al.. (2012). Outbreak of Infections by Hepatitis B Virus Genotype A and Transmission of Genetic Drug Resistance in Patients Coinfected with HIV-1 in Japan. Journal of Clinical Microbiology. 50(4). 1507–1507. 2 indexed citations
10.
Watanabe, Dai, Shiro Ibe, Tomoko Uehira, et al.. (2011). Cellular HIV-1 DNA levels in patients receiving antiretroviral therapy strongly correlate with therapy initiation timing but not with therapy duration. BMC Infectious Diseases. 11(1). 146–146. 11 indexed citations
11.
Ibe, Shiro, Yoshiyuki Yokomaku, Teiichiro Shiino, et al.. (2010). HIV-2 CRF01_AB: First Circulating Recombinant Form of HIV-2. JAIDS Journal of Acquired Immune Deficiency Syndromes. 54(3). 241–247. 39 indexed citations
12.
Fujisaki, Seiichiro, Shiro Ibe, Junko Hattori, et al.. (2009). An 11-Year Surveillance of HIV Type 1 Subtypes in Nagoya, Japan. AIDS Research and Human Retroviruses. 25(1). 15–21. 5 indexed citations
13.
Ibe, Shiro, Junko Hattori, Seiichiro Fujisaki, et al.. (2008). Trend of Drug-Resistant HIV Type 1 Emergence among Therapy-Naive Patients in Nagoya, Japan: An 8-Year Surveillance from 1999 to 2006. AIDS Research and Human Retroviruses. 24(1). 7–14. 11 indexed citations
14.
Ibe, Shiro, Seiichiro Fujisaki, Junko Hattori, et al.. (2008). Analysis of Near Full-Length Genomic Sequences of Drug-Resistant HIV-1 Spreading among Therapy-Naïve Individuals in Nagoya, Japan: Amino Acid Mutations Associated with Viral Replication Activity. AIDS Research and Human Retroviruses. 24(8). 1121–1125. 8 indexed citations
15.
Takahashi, Masaaki, Shiro Ibe, Naoya Okumura, et al.. (2007). No Observable Correlation between Central Nervous System Side Effects and EFV Plasma Concentrations in Japanese HIV Type 1-Infected Patients Treated with EFV Containing HAART. AIDS Research and Human Retroviruses. 23(8). 983–987. 25 indexed citations
16.
Gatanaga, Hiroyuki, Shiro Ibe, Mitsuhiro Matsuda, et al.. (2006). Drug-resistant HIV-1 prevalence in patients newly diagnosed with HIV/AIDS in Japan☆. Antiviral Research. 75(1). 75–82. 41 indexed citations
17.
Ibe, Shiro, et al.. (2006). Quantitative SNP‐Detection Method for Estimating HIV‐1 Replicative Fitness: Application to Protease Inhibitor‐Resistant Viruses. Microbiology and Immunology. 50(10). 765–772. 4 indexed citations
18.
Wada, Kaoru, Hiromi Nagai, Tomoko Hagiwara, et al.. (2004). Delayed HIV‐1 Infection of CD4+ T Lymphocytes from Therapy‐Naïve Patients Demonstrated by Quantification of HIV‐1 DNA Copy Numbers. Microbiology and Immunology. 48(10). 767–772. 3 indexed citations
19.
20.
Yamashita, Nobuyuki, Noriko Shimazaki, Shiro Ibe, et al.. (2001). Terminal deoxynucleotidyltransferase directly interacts with a novel nuclear protein that is homologous to p65. Genes to Cells. 6(7). 641–652. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alejandro Pironti Breakdown of academic impact, for papers by Rubén González-Sanz Breakdown of academic impact, for papers by Müşerref Tatman‐Otkun Breakdown of academic impact, for papers by Euloge Ekaza Breakdown of academic impact, for papers by Joe Huong Breakdown of academic impact, for papers by Salih Türkoğlu Breakdown of academic impact, for papers by Brenda Beckthold Breakdown of academic impact, for papers by Metin Otkun Breakdown of academic impact, for papers by Jill S. Garlick Breakdown of academic impact, for papers by L. Mensa
Rankless by CCL
2026